Early Access — free while we kick the tires
EdgarHawk

David Soergel

Chief Medical Officer

Officer

Latest: CMO selling · June 2026

1 filing analyzed · 1 company · Latest 2026-06-01

Companies

Company Buys Sells Direction
MADRIGAL PHARMACEUTICALS, INC. MDGL 0 1 Net selling

Activity

June 2026
Sell
1,042 shares
$516,561
Significance 3/10

CMO David Soergel sells 1,042 MDGL shares at $495.74 via pre-arranged 10b5-1 plan; stock at $481.23, down -6.3% in 30 days.

David Soergel sold 1,042 shares for $516,561.08 under a 10b5-1 trading plan adopted on 2026-03-02, reducing his holdings from 11,075 shares to 10,033 shares. The transaction was executed at $495.74, while the current price stands at $481.23, representing a -21.8% decline from the 52-week high of $615.00. The stock has declined -6.3% over the past 30 days despite posting +13.0% gains over 90 days. Madrigal's fundamentals show the company posted net income of $-94,391,000.00 on latest quarter revenue of $311,337,000.00, with full-year net income negative; however, annual revenue growth reached +432.0%. As a scheduled transaction under a pre-arranged plan, this sale carries no timing signal regarding executive conviction.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access